1. Medtech Insight

MDUFA IV (And More) Is Law: Trump Signs A Health-Care Bill

 
• By Sue Darcey and David Filmore

President Trump's eleventh-hour signature on the FDA Reauthorization Act puts into play about $1bn in device user-fee collections from industry through FY 2022, new US FDA performance goals and a range of device process enhancements and reforms supported by industry.

[Editors' note:Follow progress with legislation impacting the device and diagnostics industry with Medtech Insight's US Congress Tracker.]

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation